Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)
Clinical trial NCT06962332 · RECRUITING
Trial details
- NCT number
- NCT06962332
- Sponsor
- Exelixis
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2025-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.